NDC 58048-0005 Lyme And Co-infection Nosode
Angelica Archangelica,Kali Muriaticum,Yucca Filamentosa,Cartilago Suis,Phytolacca - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Code Structure Chart
Product Details
What is NDC 58048-0005?
What are the uses for Lyme And Co-infection Nosode?
What are Lyme And Co-infection Nosode Active Ingredients?
- ANGELICA ARCHANGELICA ROOT 2 [hp_X]/mL
- ANHYDROUS CITRIC ACID 6 [hp_C]/mL - A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
- ARNICA MONTANA 8 [hp_X]/mL
- BABESIA MICROTI 12 [hp_X]/mL - A species of protozoa infecting humans via the intermediate tick vector IXODES scapularis. The other hosts are the mouse PEROMYSCUS leucopus and meadow vole MICROTUS pennsylvanicus, which are fed on by the tick. Other primates can be experimentally infected with Babesia microti.
- BORRELIA BURGDORFERI 12 [hp_X]/mL - A specific species of bacteria, part of the BORRELIA BURGDORFERI GROUP, whose common name is Lyme disease spirochete.
- CAUSTICUM 6 [hp_X]/mL
- CHLAMYDIA TRACHOMATIS 12 [hp_C]/mL - Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
- GOLDENSEAL 5 [hp_X]/mL
- HUMAN HERPESVIRUS 5 6 [hp_C]/mL
- LATRODECTUS MACTANS 12 [hp_X]/mL
- LEDUM PALUSTRE TWIG 30 [hp_C]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 8 [hp_X]/mL
- MANGANESE 8 [hp_X]/mL - A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
- OXALIC ACID 8 [hp_X]/mL - A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.
- PHYTOLACCA AMERICANA ROOT 4 [hp_X]/mL
- POTASSIUM CHLORIDE 3 [hp_X]/mL - A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.
- RICKETTSIA PROWAZEKII 8 [hp_C]/mL - A species of gram-negative, aerobic bacteria that is the etiologic agent of epidemic typhus fever acquired through contact with lice (TYPHUS, EPIDEMIC LOUSE-BORNE) as well as Brill's disease.
- SUS SCROFA CARTILAGE 4 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/mL
- YUCCA FILAMENTOSA 3 [hp_X]/mL - A genus (and common name) in the Asparagaceae family. It is known for SAPONINS in the root that are used in SOAPS.
Which are Lyme And Co-infection Nosode UNII Codes?
The UNII codes for the active ingredients in this product are:
- ANGELICA ARCHANGELICA ROOT (UNII: DTN01M69SN)
- ANGELICA ARCHANGELICA ROOT (UNII: DTN01M69SN) (Active Moiety)
- POTASSIUM CHLORIDE (UNII: 660YQ98I10)
- POTASSIUM CATION (UNII: 295O53K152) (Active Moiety)
- YUCCA FILAMENTOSA (UNII: T6VR38UJ9I)
- YUCCA FILAMENTOSA (UNII: T6VR38UJ9I) (Active Moiety)
- SUS SCROFA CARTILAGE (UNII: 73ECW5WG2F)
- SUS SCROFA CARTILAGE (UNII: 73ECW5WG2F) (Active Moiety)
- PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG)
- PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG) (Active Moiety)
- GOLDENSEAL (UNII: ZW3Z11D0JV)
- GOLDENSEAL (UNII: ZW3Z11D0JV) (Active Moiety)
- TOXICODENDRON PUBESCENS LEAF (UNII: 6IO182RP7A)
- TOXICODENDRON PUBESCENS LEAF (UNII: 6IO182RP7A) (Active Moiety)
- CAUSTICUM (UNII: DD5FO1WKFU)
- CAUSTICUM (UNII: DD5FO1WKFU) (Active Moiety)
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE (UNII: HF539G9L3Q)
- MAGNESIUM CATION (UNII: T6V3LHY838) (Active Moiety)
- MANGANESE (UNII: 42Z2K6ZL8P)
- MANGANESE (UNII: 42Z2K6ZL8P) (Active Moiety)
- OXALIC ACID (UNII: 9E7R5L6H31)
- OXALIC ACID (UNII: 9E7R5L6H31) (Active Moiety)
- ARNICA MONTANA (UNII: O80TY208ZW)
- ARNICA MONTANA (UNII: O80TY208ZW) (Active Moiety)
- BABESIA MICROTI (UNII: 1948X6KEG3)
- BABESIA MICROTI (UNII: 1948X6KEG3) (Active Moiety)
- BORRELIA BURGDORFERI (UNII: 0J8NV9V5Q8)
- BORRELIA BURGDORFERI (UNII: 0J8NV9V5Q8) (Active Moiety)
- LATRODECTUS MACTANS (UNII: XJJ7QA858R)
- LATRODECTUS MACTANS (UNII: XJJ7QA858R) (Active Moiety)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) (Active Moiety)
- HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K)
- HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (Active Moiety)
- RICKETTSIA PROWAZEKII (UNII: TVS414L9M5)
- RICKETTSIA PROWAZEKII (UNII: TVS414L9M5) (Active Moiety)
- CHLAMYDIA TRACHOMATIS (UNII: T6NI39QU44)
- CHLAMYDIA TRACHOMATIS (UNII: T6NI39QU44) (Active Moiety)
- LEDUM PALUSTRE TWIG (UNII: 877L01IZ0P)
- LEDUM PALUSTRE TWIG (UNII: 877L01IZ0P) (Active Moiety)
Which are Lyme And Co-infection Nosode Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- ALCOHOL (UNII: 3K9958V90M)
Which are the Pharmacologic Classes for Lyme And Co-infection Nosode?
- Acidifying Activity - [MoA] (Mechanism of Action)
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".